Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

[Liraglutide in the treatment of diabetes type 2].

Novak B, Metelko Z.

Lijec Vjesn. 2011 Jul-Aug;133(7-8):269-76. Review. Croatian.

PMID:
22165195
2.
3.

Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes.

Ryan GJ, Hardy Y.

J Clin Pharm Ther. 2011 Jun;36(3):260-74. doi: 10.1111/j.1365-2710.2010.01180.x. Review.

PMID:
21545609
4.

Combination therapy with liraglutide and sulfonylurea for a type 2 diabetic patient with high titer of anti-insulin antibodies produced by insulin therapy.

Yoshida M, Asai M, Miyata M, Ogawa K, Maeda H, Oiso Y.

Diabetes Res Clin Pract. 2012 Jun;96(3):e55-6. doi: 10.1016/j.diabres.2011.12.024. Epub 2012 Jan 16. No abstract available.

PMID:
22257418
5.

Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results.

Jendle J, Torffvit O, Ridderstråle M, Ericsson Å, Nilsen B, Bøgelund M.

J Med Econ. 2012;15 Suppl 2:1-5. doi: 10.3111/13696998.2012.703633. Epub 2012 Aug 1.

PMID:
22853443
6.

New treatments for type 2 diabetes in the UK - an evolving landscape.

Barnett AH.

Prim Care Diabetes. 2011 Apr;5(1):1-7. doi: 10.1016/j.pcd.2010.09.001. Review.

PMID:
20934929
7.
8.

[Liraglutide: new results in the treatment of type 2 diabetes mellitus].

Mateos JL, Wajchenberg BL.

Drugs Today (Barc). 2012 Jul;48 Suppl B:1-17. doi: 10.1358/dot.2012.48(Suppl.B).1876681. Review. Portuguese.

PMID:
23082308
9.

[Glucagon-like peptide 1 analogues in the treatment of type 2 diabetes mellitus].

Christensen M, Vilsbøll T, Knop FK.

Ugeskr Laeger. 2012 Aug 20;174(34):1935; discussion 1935. Danish. No abstract available.

PMID:
23077741
10.

[Glucagon-like peptide 1 analogues in the treatment of type 2 diabetes mellitus].

Beck-Nielsen H.

Ugeskr Laeger. 2012 Jun 4;174(23):1606-8. Danish.

PMID:
22673382
11.

[Liraglutide: a human GLP-1 analogue for the treatment of diabetes mellitus type 2].

Jahn E, Sausele T.

Med Monatsschr Pharm. 2009 Nov;32(11):402-7. Review. German.

PMID:
19947303
12.

Liraglutide: a review of its use in type 2 diabetes mellitus.

Croom KF, McCormack PL.

Drugs. 2009 Oct 1;69(14):1985-2004. doi: 10.2165/11201060-000000000-00000. Review.

PMID:
19747013
13.

[Weight reducing and glucose reducing effects of liraglutide treatment for patients with type 2 diabetes].

Penninga E, Færch K, Almdal T.

Ugeskr Laeger. 2011 Jun 27;173(26):1863-9. Review. Danish.

PMID:
21712007
14.

Incretins and amylin in pediatric diabetes: new tools for management of diabetes in youth.

Wood JR, Silverstein J.

Curr Opin Pediatr. 2013 Aug;25(4):502-8. doi: 10.1097/MOP.0b013e328362fdfb. Review.

PMID:
23782574
15.

DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?

Halimi S.

Diabetes Metab. 2008 Feb;34 Suppl 2:S91-5. doi: 10.1016/S1262-3636(08)73400-1.

PMID:
18640591
16.

Liraglutide (Victoza) for type 2 diabetes.

[No authors listed]

Med Lett Drugs Ther. 2010 Apr 5;52(1335):25-7.

PMID:
20360660
17.

Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes.

Edwards CM.

Br J Hosp Med (Lond). 2013 Apr;74(4):198-201. Review. No abstract available.

PMID:
23571389
18.

Recent advances in incretin-based therapies.

Russell-Jones D, Gough S.

Clin Endocrinol (Oxf). 2012 Oct;77(4):489-99. doi: 10.1111/j.1365-2265.2012.04483.x. Review.

PMID:
22804841
19.

Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents.

Gallwitz B.

Drugs. 2011 Sep 10;71(13):1675-88. doi: 10.2165/11592810-000000000-00000. Review.

PMID:
21902291
20.

Incretin mimetics and DPP-4 inhibitors: new approach to treatment of type 2 diabetes mellitus.

Siddiqui NI.

Mymensingh Med J. 2009 Jan;18(1):113-24. Review.

PMID:
19182763
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk